Showing results (111-120 of 1,165) with videos related to

Sort By:
Pageof 117
Circulation|November 11, 2008
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for menPaul M Ridker, Nina P Paynter, Nader Rifai, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1994
Daily chlorproguanil is an effective alternative to daily proguanil in the prevention of Plasmodium falciparum malaria in KenyaC G Nevill, J D Lury, M K Mosobo, et al.
European Journal of Preventive Cardiology|January 10, 2014
Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trialBenjamin D Horne, Jeffrey L Anderson, Joseph B Muhlestein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1989
Fibromuscular dysplasia in donor kidneys--experience with three casesR Linder, H Billing, A Tibell, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Cadaveric renal graft survival: the bearing of the number of blood transfusions and of dialysis treatmentI Fehrman, J Fehrman, G Lundgren, et al.
Diabetologia|August 1, 1991
Long-term metabolic control after pancreas transplantation with enteric exocrine diversionJ Bolinder, G Tydén, A Tibell, et al.
Clinical Transplantation|June 1, 1996
Improved results with a simplified technique for pancreaticoduodenal transplantation with enteric exocrine drainageG Tydén, A Tibell, J Sandberg, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
The implications of HLA-DR match for the outcome of cadaveric renal transplantationB Berg, C G Groth, G Klintmalm, et al.
European Heart Journal|March 1, 1984
Acute myocardial infarction in renal transplant recipients: incidence and prognosisR Gunnarsson, R Löfmark, R Nondlander, et al.
Pneumologie (Stuttgart, Germany)|December 15, 2004
[Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)]M Reck, J von Pawel, C Nimmermann, et al.
Pageof 117